General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a woman having injectionMarch 22 2018

Osteoporosis patients in Birmingham are receiving injections from community pharmacies, under a new scheme.

Introduced at the start of the year, patients at University Hospitals Birmingham NHS Foundation Trust can now receive their Prolia (denosumab) injections at one of three LloydsPharmacy stores in Birmingham.

Patients assessed as suitable by their consultant or specialist nurse can choose to have their injections given by a specially trained pharmacist, rather than having to go to the hospital for it to be administered.

This service is part of LloydsPharmacy’s new healthcare centre model which is designed to deliver more treatment in community pharmacy, and is in line with the UHB commitment in bringing patient care closer to home. Services being introduced into LloydsPharmacy healthcare centre pharmacies include specialised medicine collection, subcutaneous injections, infusions clinics, as well as testing and screening.

Parent company Celesio UK said it is working in partnership with the NHS and manufacturers such as Amgen, which makes Prolia, to identify additional treatments which are suitable and able to be administered within pharmacies.

Jill Pritchard, head of speciality pharmacy at Celesio UK, said: “Traditionally, patients will travel to their hospital every six months to receive their densosumab injections which we know can be inconvenient and time consuming.

“We also know that this can add to the capacity and cost challenges at many NHS Trusts. Through this partnership, we are offering patients an alternative that means they can get their treatment in the community, closer to home.”

She added that patients who require denosumab injections can often experience pain from previous fractures. “Our pharmacy teams have expertise in pain management, which means they can provide advice and support to help patients manage these conditions as part of the injection service.”

Links:
Celesio UK announcement       

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...